PTC Therapeutics (PTCT) PT Raised to $43 at Barclays
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $71.79 --0%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 16
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 2 | Down: 7 | New: 16
Join SI Premium – FREE
Barclays raised its price target on PTC Therapeutics (NASDAQ: PTCT) to $43.00 (from $40.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Upgrades Azimut Holdings SpA (AZM:IM) (AZIHY) to Buy
- HP Enterprise (HPE) PT Raised to $86 at Raymond James
- NetApp (NTAP) PT Raised to $190 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
